Go Pro

KLA (KLAC) Financials

KLA logo
$183.99 -1.87 (-1.01%)
As of 08/21/2026 04:00 PM Eastern
Annual Income Statements for KLA

Annual Income Statements for KLA

This table shows KLA's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
704 926 802 1,176 1,217 2,078 3,322 3,387 2,762 4,062 4,831
Consolidated Net Income / (Loss)
704 926 802 1,175 1,215 2,077 3,322 3,387 2,762 4,062 4,831
Net Income / (Loss) Continuing Operations
704 926 802 1,175 1,215 2,077 3,322 3,387 2,762 4,062 4,831
Total Pre-Tax Income
858 1,173 1,456 1,296 1,317 2,360 3,489 3,789 3,190 4,644 5,606
Total Operating Income
960 503 1,540 1,389 1,339 2,488 3,654 3,995 3,346 4,775 5,661
Total Gross Profit
1,821 1,418 2,591 2,700 3,357 4,147 5,619 6,278 5,884 7,404 8,324
Total Revenue
2,984 2,704 4,037 4,569 5,806 6,919 9,212 10,496 9,812 12,156 13,579
Total Cost of Revenue
1,163 1,286 1,446 1,869 2,450 2,772 3,592 4,218 3,928 4,752 5,255
Operating Cost of Revenue
1,163 1,286 1,446 1,869 2,450 2,772 3,592 4,218 3,928 4,752 5,255
Total Operating Expenses
861 915 1,051 1,310 2,018 1,658 1,965 2,283 2,538 2,629 2,664
Selling, General & Admin Expense
379 388 442 599 734 730 860 986 970 1,030 1,132
Research & Development Expense
481 527 609 711 864 928 1,105 1,297 1,279 1,360 1,532
Impairment Charge
- - 0.00 0.00 257 - 0.00 0.00 289 239 0.00
Total Other Income / (Expense), net
-102 670 -84 -93 -23 -128 -165 -206 -156 -131 -55
Interest Expense
123 122 114 125 23 157 160 310 311 302 284
Other Income / (Expense), net
- 776 30 31 - 29 -4.61 105 155 171 230
Income Tax Expense
154 247 654 121 102 283 167 402 428 583 775
Basic Earnings per Share
$4.52 $5.92 $5.13 $7.53 $7.76 $13.49 $22.07 $24.28 $2.04 $3.05 $3.68
Weighted Average Basic Shares Outstanding
155.87M 156.47M 156.35M 156.05M 156.80M 154.09M 150.49M 139.48M 1.35B 1.33B 1.31B
Diluted Earnings per Share
$4.49 $5.88 $5.10 $7.49 $7.70 $13.37 $21.92 $24.15 $2.03 $3.04 $3.66
Weighted Average Diluted Shares Outstanding
156.78M 157.48M 157.38M 156.95M 158.01M 155.44M 151.56M 140.24M 1.36B 1.34B 1.32B
Weighted Average Basic & Diluted Shares Outstanding
155.80M 156.40M 156.40M 172.60M 155.46M 152.74M 141.80M 136.72M 134.43M 131.96M 1.31B

Quarterly Income Statements for KLA

This table shows KLA's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
583 602 836 946 825 1,088 1,203 1,121 1,146 1,201 1,363
Consolidated Net Income / (Loss)
583 602 836 946 825 1,088 1,203 1,121 1,146 1,201 1,363
Net Income / (Loss) Continuing Operations
583 602 836 946 825 1,088 1,203 1,121 1,146 1,201 1,363
Total Pre-Tax Income
691 702 945 1,079 973 1,264 1,329 1,309 1,330 1,417 1,549
Total Operating Income
733 736 977 1,120 1,003 1,300 1,352 1,337 1,362 1,408 1,554
Total Gross Profit
1,510 1,366 1,558 1,694 1,855 1,887 1,967 1,967 2,026 2,087 2,244
Total Revenue
2,487 2,360 2,569 2,842 3,077 3,063 3,175 3,210 3,297 3,415 3,658
Total Cost of Revenue
977 994 1,011 1,147 1,221 1,176 1,207 1,243 1,271 1,328 1,413
Operating Cost of Revenue
977 994 1,011 1,147 1,221 1,176 1,207 1,243 1,271 1,328 1,413
Total Operating Expenses
777 630 581 574 852 587 616 629 664 680 691
Selling, General & Admin Expense
237 238 255 251 267 249 263 269 280 291 291
Research & Development Expense
320 322 326 323 346 338 353 360 384 389 399
Total Other Income / (Expense), net
-42 -34 -32 -41 -31 -36 -23 -28 -32 9.25 -4.56
Interest Expense
74 80 83 82 75 72 73 71 70 70 73
Other Income / (Expense), net
32 46 51 41 44 36 50 43 38 80 69
Income Tax Expense
109 100 109 133 148 176 126 188 185 216 186
Basic Earnings per Share
$4.30 $4.46 $6.22 $7.05 $6.18 $8.21 $9.09 $8.51 $8.73 $9.17 $1.04
Weighted Average Basic Shares Outstanding
135.54M 134.95M 135.35M 134.13M 133.33M 132.61M 133.03M 131.76M 131.28M 130.91M 1.31B
Diluted Earnings per Share
$4.28 $4.43 $6.16 $7.01 $6.16 $8.16 $9.04 $8.47 $8.68 $9.12 $1.04
Weighted Average Diluted Shares Outstanding
136.25M 135.86M 136.19M 134.86M 133.93M 133.30M 133.75M 132.38M 132.01M 131.75M 1.32B
Basic & Diluted Earnings per Share
- - - - - - - - - - $1.04
Weighted Average Basic & Diluted Shares Outstanding
135.23M 134.64M 134.43M 133.76M 132.89M 132.24M 131.96M 131.39M 131.08M 130.63M 1.31B
Cash Dividends to Common per Share
$1.45 $1.45 $1.45 - $1.70 $1.70 - - $1.90 $1.90 $0.23

Annual Cash Flow Statements for KLA

This table details how cash moves in and out of KLA's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Change in Cash & Equivalents
270 45 251 -388 218 200 150 343 49 102 -429
Net Cash From Operating Activities
760 1,080 1,229 1,153 1,779 2,185 3,313 3,670 3,309 4,082 4,143
Net Cash From Continuing Operating Activities
760 1,080 1,229 1,153 1,779 2,185 3,313 3,670 3,309 4,082 4,143
Net Income / (Loss) Continuing Operations
704 926 802 1,175 1,215 2,077 3,322 3,387 2,762 4,062 4,831
Consolidated Net Income / (Loss)
704 926 802 1,175 1,215 2,077 3,322 3,387 2,762 4,062 4,831
Depreciation Expense
67 58 63 233 348 333 363 415 402 394 394
Non-Cash Adjustments To Reconcile Net Income
29 47 -3.36 98 418 62 179 155 501 519 316
Changes in Operating Assets and Liabilities, net
-40 49 368 -354 -202 -288 -552 -288 -356 -893 -1,398
Net Cash From Investing Activities
145 -561 292 -1,181 -259 -500 -876 -483 -1,477 -202 -1,190
Net Cash From Continuing Investing Activities
145 -561 292 -1,181 -259 -500 -876 -483 -1,477 -202 -1,190
Purchase of Property, Plant & Equipment
-32 -39 -67 -130 -153 -232 -307 -342 -277 -335 -376
Acquisitions
0.00 -29 -17 -1,819 -90 0.00 -479 -27 -3.68 0.00 0.00
Purchase of Investments
-1,244 -1,728 -548 -163 -909 -1,127 -1,109 -1,539 -2,891 -2,891 -3,976
Sale and/or Maturity of Investments
1,413 1,231 924 931 893 839 991 1,349 1,689 3,021 3,143
Other Investing Activities, net
- - - - - - - 0.00 6.51 2.46 19
Net Cash From Financing Activities
-637 -473 -1,270 -360 -1,300 -1,498 -2,257 -2,830 -1,776 -3,786 -3,386
Net Cash From Continuing Financing Activities
-637 -473 -1,270 -360 -1,300 -1,498 -2,257 -2,830 -1,776 -3,786 -3,386
Repayment of Debt
-135 -130 -946 -902 -1,171 -70 -620 -1,094 735 -750 -1.60
Repurchase of Common Equity
-182 -25 -203 -1,095 -829 -939 -3,968 -1,312 -1,736 -2,150 -2,290
Payment of Dividends
-346 -344 -402 -472 -524 -559 -639 -737 -773 -905 -1,058
Issuance of Common Equity
38 45 61 65 76 86 113 125 145 152 169
Other Financing Activities, net
-12 -19 -29 -39 -43 -56 -85 -113 -147 -133 -205
Effect of Exchange Rate Changes
2.78 - - -0.03 -1.93 - - - - 8.04 3.56
Cash Interest Paid
120 120 114 107 153 154 155 224 277 293 283
Cash Income Taxes Paid
105 234 253 180 205 326 465 495 831 887 781

Quarterly Cash Flow Statements for KLA

This table details how cash moves in and out of KLA's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
-47 183 129 0.07 -139 20 221 -133 506 -665 -137
Net Cash From Operating Activities
622 910 893 995 850 1,072 1,165 1,162 1,368 707 906
Net Cash From Continuing Operating Activities
622 910 893 995 850 1,072 1,165 1,162 1,368 707 906
Net Income / (Loss) Continuing Operations
583 602 836 946 825 1,088 1,203 1,121 1,146 1,201 1,363
Consolidated Net Income / (Loss)
583 602 836 946 825 1,088 1,203 1,121 1,146 1,201 1,363
Depreciation Expense
99 99 101 96 104 98 96 97 99 99 99
Non-Cash Adjustments To Reconcile Net Income
233 135 74 69 312 75 63 82 76 69 88
Changes in Operating Assets and Liabilities, net
-293 74 -119 -116 -391 -189 -197 -139 46 -662 -644
Net Cash From Investing Activities
-88 -858 -139 -171 614 -320 -325 -410 -113 -494 -173
Net Cash From Continuing Investing Activities
-88 -858 -139 -171 614 -320 -325 -410 -113 -494 -173
Purchase of Property, Plant & Equipment
-77 -72 -61 -60 -92 -82 -100 -96 -106 -85 -89
Purchase of Investments
-468 -1,219 -624 -856 -506 -751 -778 -1,107 -886 -1,088 -896
Sale and/or Maturity of Investments
451 436 546 745 1,212 516 549 791 863 677 812
Net Cash From Financing Activities
-591 139 -619 -838 -1,583 -735 -630 -882 -748 -879 -877
Net Cash From Continuing Financing Activities
-591 139 -619 -838 -1,583 -735 -630 -882 -748 -879 -877
Repurchase of Common Equity
-438 -372 -470 -567 -650 -507 -426 -545 -548 -626 -571
Payment of Dividends
-197 -197 -198 -198 -227 -226 -254 -254 -250 -249 -305
Issuance of Common Equity
- - 97 - - - 104 - - 0.00 113
Other Financing Activities, net
-4.68 -27 -48 -72 -3.61 -2.68 -54 -81 -5.72 -4.36 -114
Effect of Exchange Rate Changes
- -7.74 -6.00 - -19 - - -2.50 - - 6.60
Cash Interest Paid
25 113 25 131 25 129 7.77 131 7.70 131 12
Cash Income Taxes Paid
506 160 66 96 362 198 231 119 284 179 199

Annual Balance Sheets for KLA

This table presents KLA's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Total Assets
4,962 5,532 5,639 9,009 9,280 10,271 12,597 14,072 15,434 16,068 17,952
Total Current Assets
3,868 4,392 4,549 4,315 4,724 5,696 7,169 8,372 10,031 10,699 12,382
Cash & Equivalents
1,108 1,153 1,404 1,016 1,234 1,435 1,585 1,928 1,977 2,079 1,650
Short-Term Investments
1,383 1,864 1,476 723 746 1,060 1,123 1,315 2,527 2,416 3,253
Accounts Receivable
613 571 652 990 1,107 1,305 1,812 1,753 1,833 2,264 2,889
Inventories, net
699 733 932 1,263 1,311 1,575 2,147 2,877 3,035 3,212 3,649
Other Current Assets
65 71 85 323 325 321 502 499 659 728 942
Plant, Property, & Equipment, net
278 284 286 449 520 663 850 1,032 1,110 1,253 1,381
Total Noncurrent Assets
816 856 803 4,245 4,037 3,912 4,578 4,668 4,292 4,116 4,189
Goodwill
335 350 355 2,212 2,045 2,011 2,320 2,279 2,016 1,792 1,789
Intangible Assets
4.33 19 19 1,561 1,391 1,185 1,194 935 669 445 256
Noncurrent Deferred & Refundable Income Taxes
302 292 193 206 237 270 579 817 915 1,106 1,037
Other Noncurrent Operating Assets
175 196 236 266 363 445 485 637 693 774 1,107
Total Liabilities & Shareholders' Equity
4,962 5,532 5,639 9,009 9,280 10,271 12,597 14,072 15,434 16,068 17,952
Total Liabilities
4,273 4,206 4,018 6,331 6,599 6,895 11,198 11,153 12,065 11,375 11,602
Total Current Liabilities
1,002 1,293 1,214 1,768 1,700 2,103 2,871 3,743 4,661 4,086 4,305
Accounts Payable
107 147 169 202 264 342 443 371 359 459 624
Current Deferred Revenue
234 246 349 489 570 580 883 1,068 1,488 1,365 1,537
Other Current Liabilities
662 649 696 827 866 1,161 1,545 2,303 2,064 2,262 2,144
Total Noncurrent Liabilities
3,271 2,913 2,804 4,562 4,899 4,792 8,327 7,410 7,404 7,290 7,297
Long-Term Debt
3,058 2,680 2,237 3,173 3,470 3,423 6,661 5,891 5,880 5,884 5,887
Noncurrent Deferred Revenue
56 60 72 - 96 88 125 177 294 349 238
Noncurrent Deferred & Payable Income Tax Liabilities
- - 1.20 702 661 651 659 529 487 447 474
Other Noncurrent Operating Liabilities
157 172 493 687 672 631 883 813 743 610 698
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
689 1,326 1,621 2,678 2,681 3,376 1,399 2,920 3,368 4,692 6,350
Total Preferred & Common Equity
689 1,326 1,621 2,659 2,665 3,378 1,401 2,920 3,368 4,692 6,350
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
689 1,326 1,621 2,659 2,665 3,378 1,401 2,920 3,368 4,692 6,350
Common Stock
453 529 618 2,017 2,090 2,176 1,062 2,108 2,280 2,512 2,700
Retained Earnings
285 848 1,056 715 655 1,277 367 848 1,137 2,179 3,684
Accumulated Other Comprehensive Income / (Loss)
-49 -51 -54 -73 -80 -76 -27 -36 -49 1.20 -34

Quarterly Balance Sheets for KLA

This table presents KLA's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets
14,072 14,137 14,281 14,957 15,434 15,682 15,002 15,188 16,318 16,720 16,874
Total Current Assets
8,372 8,431 8,749 9,528 10,031 10,228 9,773 9,945 10,901 11,264 11,351
Cash & Equivalents
1,928 1,712 1,665 1,848 1,977 1,977 1,838 1,858 1,946 2,452 1,787
Short-Term Investments
1,315 1,638 1,678 2,446 2,527 2,653 1,942 2,171 2,737 2,755 3,171
Accounts Receivable
1,753 1,631 1,844 1,625 1,833 1,953 2,335 2,160 2,278 2,074 2,304
Inventories, net
2,877 3,008 3,039 3,007 3,035 3,110 3,046 3,156 3,297 3,283 3,437
Other Current Assets
499 443 523 601 659 536 611 601 642 700 652
Plant, Property, & Equipment, net
1,032 1,060 1,089 1,106 1,110 1,118 1,174 1,198 1,302 1,345 1,364
Total Noncurrent Assets
4,668 4,646 4,443 4,323 4,292 4,335 4,055 4,045 4,115 4,112 4,159
Goodwill
2,279 2,279 2,086 2,016 2,016 2,016 1,785 1,788 1,791 1,791 1,788
Intangible Assets
935 872 786 728 669 612 549 496 397 348 301
Noncurrent Deferred & Refundable Income Taxes
817 870 902 879 915 982 1,002 1,023 1,131 1,144 1,123
Other Noncurrent Operating Assets
637 625 668 700 693 726 719 739 795 829 946
Total Liabilities & Shareholders' Equity
14,072 14,137 14,281 14,957 15,434 15,682 15,002 15,188 16,318 16,720 16,874
Total Liabilities
11,153 11,147 11,237 11,862 12,065 12,122 11,417 11,184 11,333 11,254 11,043
Total Current Liabilities
3,743 3,818 4,571 4,459 4,661 4,798 4,138 3,910 4,050 3,982 3,752
Accounts Payable
371 364 377 355 359 377 433 429 430 425 515
Current Deferred Revenue
1,068 1,073 1,330 1,445 1,488 1,390 1,594 1,377 1,424 1,457 1,197
Other Current Liabilities
2,303 2,381 2,114 1,909 2,064 2,282 2,111 2,103 2,197 2,100 2,039
Total Noncurrent Liabilities
7,410 7,329 6,666 7,404 7,404 7,324 7,279 7,274 7,283 7,272 7,291
Long-Term Debt
5,891 5,892 5,143 5,879 5,880 5,881 5,882 5,883 5,885 5,886 5,887
Noncurrent Deferred Revenue
177 192 222 271 294 320 334 352 287 271 252
Noncurrent Deferred & Payable Income Tax Liabilities
529 506 494 480 487 472 424 406 465 453 444
Other Noncurrent Operating Liabilities
813 739 807 773 743 651 639 632 646 663 709
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,920 2,990 3,044 3,095 3,368 3,560 3,585 4,005 4,985 5,466 5,830
Total Preferred & Common Equity
2,920 2,990 3,044 3,095 3,368 3,560 3,585 4,005 4,985 5,466 5,830
Total Common Equity
2,920 2,990 3,044 3,095 3,368 3,560 3,585 4,005 4,985 5,466 5,830
Common Stock
2,108 2,073 2,155 2,178 2,280 2,257 2,346 2,401 2,489 2,604 2,675
Retained Earnings
848 966 921 959 1,137 1,328 1,285 1,646 2,495 2,861 3,187
Accumulated Other Comprehensive Income / (Loss)
-36 -49 -32 -42 -49 -26 -46 -43 0.67 0.96 -32

Annual Metrics And Ratios for KLA

This table displays calculated financial ratios and metrics derived from KLA's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
DEI Shares Outstanding
- - - - - - - - - - 130,627,521.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 1,306,275,210.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 3.70
Growth Metrics
- - - - - - - - - - -
Revenue Growth
6.06% -9.40% 49.29% 13.18% 27.09% 19.16% 33.14% 13.94% -6.51% 23.89% 11.71%
EBITDA Growth
68.37% 30.11% 22.16% 1.29% 2.01% 68.98% 40.75% 12.50% -13.55% 36.84% 17.67%
EBIT Growth
81.33% 33.16% 22.79% -9.52% -5.74% 88.00% 44.95% 12.33% -14.59% 41.28% 19.08%
NOPAT Growth
41.33% -49.66% 113.79% 48.43% -1.88% 77.21% 58.86% 2.64% -18.87% 44.14% 16.81%
Net Income Growth
92.38% 31.47% -13.37% 46.46% 3.40% 70.97% 59.92% 1.97% -18.46% 47.06% 18.94%
EPS Growth
100.45% 30.96% -13.27% 46.86% 2.80% 73.64% 63.95% 10.17% -16.02% 49.75% 20.39%
Operating Cash Flow Growth
25.38% 42.12% 13.84% -6.22% 54.33% 22.83% 51.61% 10.78% -9.84% 23.37% 1.50%
Free Cash Flow Firm Growth
27.31% -45.53% 169.33% -291.23% 167.18% 42.67% 20.37% 36.89% -11.49% 20.82% 1.03%
Invested Capital Growth
2.53% -1.24% -21.17% 346.17% -4.39% 3.69% 23.77% 4.03% -1.31% 10.69% 20.60%
Revenue Q/Q Growth
5.77% -21.86% 29.00% 10.99% -1.07% 7.22% 6.49% -1.24% 2.23% 5.25% 3.69%
EBITDA Q/Q Growth
16.14% 0.05% 116.80% 18.07% -14.74% 23.90% 6.07% -1.96% 4.70% 7.43% 3.68%
EBIT Q/Q Growth
18.20% 0.10% 127.18% 10.95% -15.34% 27.58% 6.21% -2.25% 5.38% 8.18% 3.89%
NOPAT Q/Q Growth
18.91% -61.17% 137.75% 10.77% -12.64% 23.06% 4.42% -3.79% 5.00% 9.41% 3.04%
Net Income Q/Q Growth
22.53% -1.63% 13.05% -10.06% 18.88% 12.01% 5.47% -3.44% 5.82% 9.92% 3.43%
EPS Q/Q Growth
23.35% -1.84% 13.59% -11.05% 21.07% 12.07% 6.51% -1.59% 5.90% 10.48% -89.63%
Operating Cash Flow Q/Q Growth
5.06% 11.18% -6.76% -4.00% 7.71% 0.59% 11.95% 3.96% -1.97% 7.15% -5.87%
Free Cash Flow Firm Q/Q Growth
4.99% -56.86% 36.59% 8.89% -15.59% 13.00% 9.26% 3.88% -1.40% 5.95% -5.44%
Invested Capital Q/Q Growth
-5.76% -11.33% 3.77% -1.12% 0.86% 5.15% 2.91% -2.02% 1.20% 3.80% 8.51%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
61.02% 52.43% 64.18% 59.08% 57.81% 59.93% 61.00% 59.81% 59.97% 60.91% 61.30%
EBITDA Margin
34.42% 49.44% 40.45% 36.20% 29.06% 41.21% 43.56% 43.01% 39.78% 43.93% 46.28%
Operating Margin
32.18% 18.60% 38.15% 30.41% 23.07% 35.97% 39.67% 38.06% 34.10% 39.28% 41.69%
EBIT Margin
32.18% 47.30% 38.90% 31.10% 23.07% 36.39% 39.62% 39.06% 35.68% 40.69% 43.38%
Profit (Net Income) Margin
23.60% 34.25% 19.87% 25.72% 20.93% 30.03% 36.06% 32.27% 28.15% 33.41% 35.57%
Tax Burden Percent
82.08% 78.93% 55.10% 90.65% 92.28% 88.01% 95.21% 89.40% 86.58% 87.45% 86.17%
Interest Burden Percent
89.35% 91.74% 92.72% 91.23% 98.32% 93.75% 95.61% 92.43% 91.11% 93.89% 95.17%
Effective Tax Rate
17.92% 21.07% 44.90% 9.35% 7.72% 11.99% 4.79% 10.60% 13.42% 12.55% 13.83%
Return on Invested Capital (ROIC)
63.56% 31.80% 76.52% 47.18% 28.97% 51.57% 71.91% 65.41% 52.38% 72.14% 72.71%
ROIC Less NNEP Spread (ROIC-NNEP)
51.31% 252.13% 89.20% 30.96% 27.66% 42.32% 65.51% 59.84% 46.72% 65.64% 68.73%
Return on Net Nonoperating Assets (RNNOA)
63.30% 60.09% -22.07% 7.50% 16.38% 17.03% 67.24% 91.45% 35.46% 28.63% 14.78%
Return on Equity (ROE)
126.86% 91.89% 54.45% 54.67% 45.35% 68.60% 139.15% 156.86% 87.85% 100.78% 87.50%
Cash Return on Invested Capital (CROIC)
61.06% 33.06% 100.20% -79.59% 33.46% 47.95% 50.67% 61.46% 53.70% 61.99% 54.04%
Operating Return on Assets (OROA)
19.62% 24.37% 28.11% 19.40% 14.65% 25.76% 31.92% 30.74% 23.73% 31.41% 34.63%
Return on Assets (ROA)
14.39% 17.65% 14.36% 16.04% 13.29% 21.25% 29.05% 25.40% 18.72% 25.79% 28.40%
Return on Common Equity (ROCE)
126.86% 91.89% 54.45% 54.44% 45.06% 68.44% 139.27% 156.95% 87.85% 100.78% 87.50%
Return on Equity Simple (ROE_SIMPLE)
102.22% 69.82% 49.51% 44.19% 45.58% 61.50% 237.06% 116.02% 82.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
788 397 848 1,259 1,236 2,190 3,479 3,571 2,897 4,176 4,878
NOPAT Margin
26.42% 14.68% 21.02% 27.57% 21.28% 31.65% 37.77% 34.02% 29.53% 34.35% 35.92%
Net Nonoperating Expense Percent (NNEP)
12.25% -220.33% -12.68% 16.22% 1.31% 9.25% 6.41% 5.57% 5.67% 6.50% 3.98%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - 39.48% 39.86%
Cost of Revenue to Revenue
38.98% 47.57% 35.82% 40.92% 42.19% 40.07% 39.00% 40.19% 40.03% 39.09% 38.70%
SG&A Expenses to Revenue
12.71% 14.36% 10.96% 13.11% 12.64% 10.55% 9.34% 9.40% 9.88% 8.47% 8.33%
R&D to Revenue
16.13% 19.48% 15.08% 15.56% 14.88% 13.42% 12.00% 12.35% 13.03% 11.19% 11.28%
Operating Expenses to Revenue
28.84% 33.84% 26.03% 28.68% 34.75% 23.97% 21.33% 21.75% 25.87% 21.63% 19.62%
Earnings before Interest and Taxes (EBIT)
960 1,279 1,570 1,421 1,339 2,518 3,650 4,099 3,501 4,947 5,890
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,027 1,337 1,633 1,654 1,687 2,851 4,013 4,515 3,903 5,341 6,284
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
14.24 9.55 8.93 6.69 10.75 14.18 33.14 22.53 32.90 25.24 62.07
Price to Tangible Book Value (P/TBV)
28.06 13.22 11.61 0.00 0.00 264.53 0.00 0.00 162.04 48.24 91.54
Price to Revenue (P/Rev)
3.29 4.68 3.58 3.90 4.94 6.92 5.04 6.27 11.29 9.74 29.02
Price to Earnings (P/E)
13.93 13.68 18.04 15.14 23.56 23.05 13.98 19.42 40.12 29.16 81.58
Dividend Yield
3.30% 2.65% 2.71% 2.72% 1.79% 1.15% 1.35% 1.08% 0.69% 0.75% 0.00%
Earnings Yield
7.18% 7.31% 5.54% 6.61% 4.25% 4.34% 7.15% 5.15% 2.49% 3.43% 1.23%
Enterprise Value to Invested Capital (EV/IC)
8.26 10.14 14.14 4.47 7.23 11.30 9.42 12.29 20.55 19.70 53.87
Enterprise Value to Revenue (EV/Rev)
3.48 4.65 3.43 4.27 5.20 7.06 5.47 6.52 11.51 9.86 29.10
Enterprise Value to EBITDA (EV/EBITDA)
10.10 9.41 8.47 11.79 17.88 17.13 12.56 15.16 28.94 22.44 62.87
Enterprise Value to EBIT (EV/EBIT)
10.80 9.84 8.80 13.72 22.52 19.40 13.81 16.69 32.26 24.23 67.08
Enterprise Value to NOPAT (EV/NOPAT)
13.16 31.70 16.29 15.48 24.41 22.30 14.48 19.16 38.98 28.70 81.00
Enterprise Value to Operating Cash Flow (EV/OCF)
13.66 11.65 11.25 16.92 16.96 22.35 15.21 18.65 34.13 29.36 95.36
Enterprise Value to Free Cash Flow (EV/FCFF)
13.70 30.50 12.44 0.00 21.14 23.99 20.56 20.39 38.03 33.40 108.98
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
4.44 2.21 1.38 1.28 1.29 1.02 4.76 2.02 1.97 1.25 0.93
Long-Term Debt to Equity
4.44 2.02 1.38 1.19 1.29 1.01 4.76 2.02 1.75 1.25 0.93
Financial Leverage
1.23 0.24 -0.25 0.24 0.59 0.40 1.03 1.53 0.76 0.44 0.22
Leverage Ratio
8.81 5.21 3.79 3.41 3.41 3.23 4.79 6.18 4.69 3.91 3.08
Compound Leverage Factor
7.88 4.78 3.51 3.11 3.36 3.03 4.58 5.71 4.28 3.67 2.93
Debt to Total Capital
81.61% 68.84% 58.00% 56.11% 56.41% 50.49% 82.64% 66.86% 66.31% 55.63% 48.11%
Short-Term Debt to Total Capital
0.00% 5.87% 0.00% 4.10% 0.00% 0.29% 0.00% 0.00% 7.50% 0.00% 0.00%
Long-Term Debt to Total Capital
81.61% 62.97% 58.00% 52.01% 56.41% 50.20% 82.64% 66.86% 58.81% 55.63% 48.11%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.30% 0.25% -0.03% -0.03% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
18.39% 31.16% 42.00% 43.58% 43.34% 49.54% 17.39% 33.14% 33.69% 44.37% 51.89%
Debt to EBITDA
2.98 2.19 1.37 2.07 2.06 1.21 1.66 1.30 1.70 1.10 0.94
Net Debt to EBITDA
0.55 -0.06 -0.39 1.02 0.88 0.33 0.99 0.59 0.54 0.26 0.16
Long-Term Debt to EBITDA
2.98 2.01 1.37 1.92 2.06 1.20 1.66 1.30 1.51 1.10 0.94
Debt to NOPAT
3.88 7.38 2.64 2.72 2.81 1.57 1.91 1.65 2.29 1.41 1.21
Net Debt to NOPAT
0.72 -0.22 -0.76 1.34 1.21 0.43 1.14 0.74 0.73 0.33 0.20
Long-Term Debt to NOPAT
3.88 6.75 2.64 2.52 2.81 1.56 1.91 1.65 2.03 1.41 1.21
Altman Z-Score
3.39 3.95 4.77 3.16 4.20 6.24 4.63 5.73 7.42 8.70 23.05
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.43% 0.64% 0.23% -0.09% -0.05% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.86 3.40 3.75 2.44 2.78 2.71 2.50 2.24 2.15 2.62 2.88
Quick Ratio
3.10 2.77 2.91 1.54 1.82 1.81 1.57 1.34 1.36 1.65 1.81
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
757 413 1,111 -2,125 1,427 2,036 2,451 3,356 2,970 3,588 3,625
Operating Cash Flow to CapEx
3,080.06% 3,028.77% 1,835.96% 883.26% 1,165.12% 950.95% 1,184.54% 1,074.33% 1,215.03% 1,218.12% 1,102.04%
Free Cash Flow to Firm to Interest Expense
6.16 3.37 9.71 -17.05 63.33 12.94 15.29 10.82 9.54 11.88 12.75
Operating Cash Flow to Interest Expense
6.18 8.82 10.75 9.25 78.93 13.89 20.66 11.83 10.63 13.51 14.57
Operating Cash Flow Less CapEx to Interest Expense
5.98 8.52 10.16 8.20 72.15 12.43 18.92 10.73 9.76 12.40 13.24
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.61 0.52 0.72 0.62 0.64 0.71 0.81 0.79 0.67 0.77 0.80
Accounts Receivable Turnover
4.98 4.57 6.60 5.57 5.54 5.73 5.91 5.89 5.47 5.93 5.27
Inventory Turnover
1.77 1.80 1.74 1.70 1.90 1.92 1.93 1.68 1.33 1.52 1.53
Fixed Asset Turnover
10.07 9.62 14.16 12.43 11.99 11.70 12.18 11.16 9.16 10.29 10.31
Accounts Payable Turnover
11.09 10.13 9.13 10.06 10.50 9.14 9.15 10.36 10.75 11.62 9.71
Days Sales Outstanding (DSO)
73.30 79.94 55.28 65.58 65.93 63.65 61.76 61.99 66.70 61.51 69.25
Days Inventory Outstanding (DIO)
206.52 203.13 210.11 214.23 191.73 190.02 189.10 217.34 274.65 239.92 238.26
Days Payable Outstanding (DPO)
32.92 36.03 39.97 36.29 34.77 39.92 39.90 35.23 33.94 31.42 37.58
Cash Conversion Cycle (CCC)
246.91 247.04 225.42 243.51 222.89 213.75 210.95 244.10 307.42 270.01 269.93
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,256 1,240 978 4,362 4,170 4,324 5,352 5,567 5,494 6,082 7,335
Invested Capital Turnover
2.41 2.17 3.64 1.71 1.36 1.63 1.90 1.92 1.77 2.10 2.02
Increase / (Decrease) in Invested Capital
31 -16 -263 3,384 -191 154 1,028 216 -73 588 1,253
Enterprise Value (EV)
10,377 12,581 13,826 19,499 30,166 48,844 50,390 68,428 112,935 119,844 395,101
Market Capitalization
9,810 12,667 14,469 17,796 28,661 47,898 46,439 65,780 110,809 118,454 394,116
Book Value per Share
$4.43 $8.46 $10.40 $16.45 $17.19 $22.03 $9.39 $21.28 $25.02 $35.48 $48.61
Tangible Book Value per Share
$2.25 $6.11 $8.00 ($6.89) ($4.98) $1.18 ($14.16) ($2.15) $5.08 $18.57 $32.96
Total Capital
3,747 4,257 3,858 6,101 6,151 6,818 8,060 8,810 9,998 10,577 12,237
Total Debt
3,058 2,930 2,237 3,423 3,470 3,443 6,661 5,891 6,630 5,884 5,887
Total Long-Term Debt
3,058 2,680 2,237 3,173 3,470 3,423 6,661 5,891 5,880 5,884 5,887
Net Debt
567 -86 -643 1,684 1,489 948 3,953 2,648 2,126 1,390 985
Capital Expenditures (CapEx)
25 36 67 130 153 230 280 342 272 335 376
Debt-free, Cash-free Net Working Capital (DFCFNWC)
374 332 454 1,057 1,043 1,118 1,590 1,386 1,616 2,118 3,174
Debt-free Net Working Capital (DFNWC)
2,866 3,349 3,335 2,797 3,024 3,613 4,298 4,629 6,120 6,613 8,077
Net Working Capital (NWC)
2,866 3,099 3,335 2,547 3,024 3,593 4,298 4,629 5,370 6,613 8,077
Net Nonoperating Expense (NNE)
84 -529 46 84 21 113 157 184 135 114 47
Net Nonoperating Obligations (NNO)
567 -86 -643 1,684 1,489 948 3,953 2,648 2,126 1,390 985
Total Depreciation and Amortization (D&A)
67 58 63 233 348 333 363 415 402 394 394
Debt-free, Cash-free Net Working Capital to Revenue
12.54% 12.28% 11.26% 23.14% 17.97% 16.17% 17.26% 13.21% 16.47% 17.43% 23.38%
Debt-free Net Working Capital to Revenue
96.02% 123.85% 82.61% 61.21% 52.08% 52.22% 46.66% 44.10% 62.37% 54.40% 59.48%
Net Working Capital to Revenue
96.02% 114.61% 82.61% 55.74% 52.08% 51.93% 46.66% 44.10% 54.73% 54.40% 59.48%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$4.52 $5.92 $5.13 $7.53 $7.76 $13.49 $22.07 $24.28 $20.41 $30.53 $3.68
Adjusted Weighted Average Basic Shares Outstanding
155.87M 156.47M 156.35M 156.05M 156.80M 154.09M 150.49M 139.48M 135.35M 133.03M 1.31B
Adjusted Diluted Earnings per Share
$4.49 $5.88 $5.10 $7.49 $7.70 $13.37 $21.92 $24.15 $20.28 $30.37 $3.66
Adjusted Weighted Average Diluted Shares Outstanding
156.78M 157.48M 157.38M 156.95M 158.01M 155.44M 151.56M 140.24M 136.19M 133.75M 1.32B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
156.00M 156.84M 156.13M 159.26M 155.46M 152.74M 141.80M 136.72M 134.43M 131.96M 1.31B
Normalized Net Operating Profit after Tax (NOPAT)
788 397 848 1,259 1,473 2,190 3,479 3,571 3,148 4,385 4,878
Normalized NOPAT Margin
26.42% 14.68% 21.02% 27.57% 25.36% 31.65% 37.77% 34.02% 32.08% 36.07% 35.92%
Pre Tax Income Margin
28.76% 43.39% 36.07% 28.37% 22.68% 34.12% 37.88% 36.10% 32.51% 38.21% 41.28%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
7.82 10.44 13.73 11.40 59.42 16.00 22.76 13.21 11.25 16.37 20.71
NOPAT to Interest Expense
6.42 3.24 7.42 10.11 54.83 13.92 21.70 11.51 9.31 13.82 17.15
EBIT Less CapEx to Interest Expense
7.62 10.15 13.14 10.36 52.65 14.54 21.02 12.11 10.37 15.26 19.39
NOPAT Less CapEx to Interest Expense
6.21 2.95 6.83 9.06 48.06 12.46 19.95 10.41 8.43 12.71 15.83
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
49.16% 37.15% 50.12% 40.19% 43.10% 26.93% 19.24% 21.75% 27.99% 22.27% 21.90%
Augmented Payout Ratio
74.95% 39.85% 75.44% 133.40% 111.33% 72.11% 138.68% 60.48% 90.84% 75.20% 69.30%

Quarterly Metrics And Ratios for KLA

This table displays calculated financial ratios and metrics derived from KLA's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - - - - 131,076,611.00 130,627,521.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 131,076,611.00 1,306,275,210.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 9.16 1.04
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-16.66% -2.99% 9.07% 18.55% 23.73% 29.80% 23.59% 12.96% 7.16% 11.49% 15.21%
EBITDA Growth
-34.54% -10.10% 18.35% 22.20% 33.19% 62.77% 32.71% 17.58% 30.21% 10.59% 14.89%
EBIT Growth
-37.11% -10.68% 21.07% 25.37% 36.85% 70.89% 36.39% 18.93% 33.65% 11.29% 15.75%
NOPAT Growth
-39.82% -15.87% 18.88% 25.46% 37.61% 77.40% 41.46% 16.57% 37.95% 6.59% 11.72%
Net Income Growth
-40.48% -13.80% 22.17% 27.58% 41.54% 80.94% 43.80% 18.52% 38.95% 10.34% 13.32%
EPS Growth
-37.88% -11.93% 22.47% 29.57% 43.93% 84.20% 46.75% 20.83% 40.91% 11.76% 15.56%
Operating Cash Flow Growth
-9.60% -9.98% -6.93% 12.62% 36.52% 17.82% 30.51% 16.71% 60.99% -34.02% -22.19%
Free Cash Flow Firm Growth
710.62% 229.45% 83.13% 34.00% -13.47% -21.99% -32.19% -45.51% -5.56% -57.51% -82.02%
Invested Capital Growth
-4.40% -4.45% -1.31% 0.52% 1.66% 7.92% 10.69% 11.24% 8.05% 15.36% 20.60%
Revenue Q/Q Growth
3.75% -5.10% 8.85% 10.62% 8.28% -0.45% 3.65% 1.10% 2.72% 3.58% 7.10%
EBITDA Q/Q Growth
-15.93% 1.93% 28.10% 11.32% -8.38% 24.58% 4.45% -1.38% 1.47% 5.81% 8.51%
EBIT Q/Q Growth
-17.33% 2.16% 31.44% 12.94% -9.76% 27.57% 4.91% -1.52% 1.41% 6.23% 9.11%
NOPAT Q/Q Growth
-21.05% 2.11% 37.09% 13.53% -13.40% 31.63% 9.31% -6.45% 2.48% 1.71% 14.58%
Net Income Q/Q Growth
-21.43% 3.26% 39.05% 13.08% -12.83% 32.00% 10.51% -6.80% 2.20% 4.83% 13.49%
EPS Q/Q Growth
-20.89% 3.50% 39.05% 13.80% -12.13% 32.47% 10.78% -6.31% 2.48% 5.07% -88.60%
Operating Cash Flow Q/Q Growth
-29.59% 46.24% -1.91% 11.50% -14.64% 26.21% 8.66% -0.29% 17.74% -48.27% 28.13%
Free Cash Flow Firm Q/Q Growth
23.02% 0.98% 6.12% 1.64% -20.56% -8.96% -7.75% -18.33% 37.70% -59.04% -60.97%
Invested Capital Q/Q Growth
1.10% -2.93% 1.20% 1.22% 2.25% 3.04% 3.80% 1.72% -0.68% 10.01% 8.51%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
60.72% 57.88% 60.66% 59.62% 60.30% 61.62% 61.97% 61.27% 61.45% 61.12% 61.36%
EBITDA Margin
34.77% 37.34% 43.95% 44.23% 37.42% 46.83% 47.19% 46.03% 45.47% 46.45% 47.06%
Operating Margin
29.49% 31.20% 38.05% 39.41% 32.60% 42.45% 42.58% 41.66% 41.31% 41.21% 42.49%
EBIT Margin
30.78% 33.14% 40.02% 40.85% 34.04% 43.63% 44.16% 43.01% 42.46% 43.55% 44.36%
Profit (Net Income) Margin
23.43% 25.49% 32.56% 33.29% 26.80% 35.53% 37.89% 34.93% 34.75% 35.17% 37.27%
Tax Burden Percent
84.27% 85.69% 88.51% 87.69% 84.78% 86.08% 90.52% 85.61% 86.12% 84.77% 87.97%
Interest Burden Percent
90.31% 89.77% 91.94% 92.92% 92.84% 94.62% 94.78% 94.85% 95.02% 95.26% 95.48%
Effective Tax Rate
15.73% 14.31% 11.49% 12.31% 15.22% 13.92% 9.48% 14.39% 13.88% 15.23% 12.03%
Return on Invested Capital (ROIC)
42.00% 46.19% 59.74% 63.90% 53.16% 74.78% 80.95% 76.04% 76.65% 72.52% 75.66%
ROIC Less NNEP Spread (ROIC-NNEP)
40.78% 45.09% 58.54% 62.31% 52.04% 73.30% 79.76% 74.56% 74.68% 73.08% 75.32%
Return on Net Nonoperating Assets (RNNOA)
41.86% 41.63% 44.45% 43.23% 36.52% 43.25% 34.79% 27.95% 22.95% 20.69% 16.20%
Return on Equity (ROE)
83.87% 87.82% 104.19% 107.13% 89.68% 118.03% 115.73% 104.00% 99.60% 93.21% 91.86%
Cash Return on Invested Capital (CROIC)
54.80% 54.21% 53.70% 55.31% 57.36% 60.00% 61.99% 63.22% 71.06% 60.76% 54.04%
Operating Return on Assets (OROA)
21.26% 22.21% 26.61% 28.10% 25.22% 33.43% 34.08% 33.67% 34.12% 35.58% 35.42%
Return on Assets (ROA)
16.18% 17.09% 21.66% 22.90% 19.85% 27.23% 29.24% 27.34% 27.92% 28.73% 29.75%
Return on Common Equity (ROCE)
83.87% 87.82% 104.19% 107.13% 89.68% 118.03% 115.73% 104.00% 99.60% 93.21% 91.86%
Return on Equity Simple (ROE_SIMPLE)
88.92% 84.34% 0.00% 83.33% 89.51% 92.27% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
618 631 865 982 850 1,119 1,224 1,145 1,173 1,193 1,367
NOPAT Margin
24.85% 26.74% 33.67% 34.56% 27.64% 36.54% 38.54% 35.67% 35.58% 34.94% 37.38%
Net Nonoperating Expense Percent (NNEP)
1.22% 1.10% 1.20% 1.59% 1.11% 1.48% 1.18% 1.48% 1.97% -0.56% 0.34%
Return On Investment Capital (ROIC_SIMPLE)
6.92% - - - 8.98% 11.32% 11.57% 10.53% 10.33% 10.18% 11.17%
Cost of Revenue to Revenue
39.28% 42.12% 39.34% 40.38% 39.70% 38.38% 38.03% 38.73% 38.55% 38.88% 38.64%
SG&A Expenses to Revenue
9.54% 10.06% 9.93% 8.83% 8.68% 8.13% 8.27% 8.38% 8.49% 8.53% 7.97%
R&D to Revenue
12.89% 13.63% 12.68% 11.37% 11.25% 11.04% 11.12% 11.23% 11.64% 11.38% 10.91%
Operating Expenses to Revenue
31.23% 26.68% 22.61% 20.21% 27.70% 19.16% 19.39% 19.61% 20.13% 19.91% 18.88%
Earnings before Interest and Taxes (EBIT)
765 782 1,028 1,161 1,048 1,336 1,402 1,381 1,400 1,487 1,623
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
865 881 1,129 1,257 1,151 1,434 1,498 1,478 1,499 1,586 1,721
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
25.73 30.41 32.90 29.24 23.51 22.56 25.24 28.55 29.21 33.10 62.07
Price to Tangible Book Value (P/TBV)
457.29 267.68 162.04 111.70 67.40 52.47 48.24 50.89 47.99 51.59 91.54
Price to Revenue (P/Rev)
8.10 9.80 11.29 10.15 7.77 7.82 9.74 11.36 12.53 14.74 29.02
Price to Earnings (P/E)
28.94 36.05 40.12 35.09 26.27 24.45 29.16 33.59 35.03 41.32 81.58
Dividend Yield
0.93% 0.79% 0.69% 0.75% 0.96% 0.93% 0.75% 0.67% 0.61% 0.52% 0.00%
Earnings Yield
3.46% 2.77% 2.49% 2.85% 3.81% 4.09% 3.43% 2.98% 2.85% 2.42% 1.23%
Enterprise Value to Invested Capital (EV/IC)
14.46 17.76 20.55 19.08 15.19 15.73 19.70 23.20 26.09 28.69 53.87
Enterprise Value to Revenue (EV/Rev)
8.36 10.05 11.51 10.34 7.96 7.98 9.86 11.46 12.58 14.81 29.10
Enterprise Value to EBITDA (EV/EBITDA)
21.13 25.87 28.94 25.68 19.55 18.54 22.44 25.81 27.13 31.99 62.87
Enterprise Value to EBIT (EV/EBIT)
23.68 29.03 32.26 28.40 21.50 20.16 24.23 27.78 29.05 34.20 67.08
Enterprise Value to NOPAT (EV/NOPAT)
28.10 34.95 38.98 34.26 25.95 24.16 28.70 33.08 34.40 40.96 81.00
Enterprise Value to Operating Cash Flow (EV/OCF)
23.27 28.57 34.13 31.02 23.68 24.20 29.36 33.79 33.64 44.06 95.36
Enterprise Value to Free Cash Flow (EV/FCFF)
25.79 32.02 38.03 34.59 26.70 27.22 33.40 38.65 38.14 50.58 108.98
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.94 2.14 1.97 1.86 1.64 1.47 1.25 1.18 1.08 1.01 0.93
Long-Term Debt to Equity
1.69 1.90 1.75 1.65 1.64 1.47 1.25 1.18 1.08 1.01 0.93
Financial Leverage
1.03 0.92 0.76 0.69 0.70 0.59 0.44 0.37 0.31 0.28 0.22
Leverage Ratio
4.96 4.96 4.69 4.55 4.42 4.25 3.91 3.74 3.51 3.26 3.08
Compound Leverage Factor
4.48 4.45 4.31 4.23 4.10 4.02 3.70 3.55 3.33 3.11 2.94
Debt to Total Capital
65.94% 68.17% 66.31% 65.07% 62.14% 59.50% 55.63% 54.14% 51.85% 50.24% 48.11%
Short-Term Debt to Total Capital
8.39% 7.71% 7.50% 7.36% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
57.55% 60.46% 58.81% 57.71% 62.14% 59.50% 55.63% 54.14% 51.85% 50.24% 48.11%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
34.06% 31.83% 33.69% 34.93% 37.86% 40.50% 44.37% 45.86% 48.15% 49.76% 51.89%
Debt to EBITDA
1.54 1.78 1.70 1.61 1.33 1.18 1.10 1.06 1.00 0.97 0.94
Net Debt to EBITDA
0.67 0.63 0.54 0.48 0.48 0.37 0.26 0.22 0.11 0.15 0.16
Long-Term Debt to EBITDA
1.34 1.58 1.51 1.42 1.33 1.18 1.10 1.06 1.00 0.97 0.94
Debt to NOPAT
2.05 2.40 2.29 2.14 1.77 1.54 1.41 1.36 1.26 1.24 1.21
Net Debt to NOPAT
0.89 0.85 0.73 0.65 0.63 0.49 0.33 0.28 0.15 0.20 0.20
Long-Term Debt to NOPAT
1.79 2.13 2.03 1.90 1.77 1.54 1.41 1.36 1.26 1.24 1.21
Altman Z-Score
5.48 6.07 6.89 6.59 5.95 6.53 7.98 9.30 10.31 12.36 22.26
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.91 2.14 2.15 2.13 2.36 2.54 2.62 2.69 2.83 3.03 2.88
Quick Ratio
1.13 1.33 1.36 1.37 1.48 1.58 1.65 1.72 1.83 1.94 1.81
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
875 884 938 953 757 689 636 519 715 293 114
Operating Cash Flow to CapEx
810.20% 1,267.50% 1,469.45% 1,647.94% 920.16% 1,305.36% 1,160.26% 1,211.33% 1,295.38% 830.47% 1,015.18%
Free Cash Flow to Firm to Interest Expense
11.79 11.05 11.32 11.60 10.10 9.59 8.70 7.31 10.27 4.16 1.56
Operating Cash Flow to Interest Expense
8.39 11.38 10.78 12.11 11.33 14.91 15.93 16.34 19.63 10.05 12.37
Operating Cash Flow Less CapEx to Interest Expense
7.35 10.48 10.04 11.38 10.10 13.77 14.56 14.99 18.11 8.84 11.15
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.69 0.67 0.67 0.69 0.74 0.77 0.77 0.78 0.80 0.82 0.80
Accounts Receivable Turnover
4.69 5.38 5.47 5.72 5.19 6.10 5.93 5.92 5.78 5.87 5.27
Inventory Turnover
1.40 1.35 1.33 1.35 1.44 1.48 1.52 1.51 1.55 1.53 1.53
Fixed Asset Turnover
9.42 9.18 9.16 9.42 9.59 10.02 10.29 10.35 10.12 10.22 10.31
Accounts Payable Turnover
8.58 10.14 10.75 11.16 10.80 11.62 11.62 12.02 11.41 10.69 9.71
Days Sales Outstanding (DSO)
77.87 67.79 66.70 63.77 70.31 59.81 61.51 61.65 63.13 62.21 69.25
Days Inventory Outstanding (DIO)
261.38 270.74 274.65 270.42 253.93 246.91 239.92 241.22 235.85 238.29 238.26
Days Payable Outstanding (DPO)
42.53 36.01 33.94 32.72 33.78 31.41 31.42 30.36 31.98 34.13 37.58
Cash Conversion Cycle (CCC)
296.71 302.53 307.42 301.47 290.45 275.31 270.01 272.51 267.01 266.37 269.93
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
5,593 5,429 5,494 5,561 5,687 5,859 6,082 6,187 6,144 6,760 7,335
Invested Capital Turnover
1.69 1.73 1.77 1.85 1.92 2.05 2.10 2.13 2.15 2.08 2.02
Increase / (Decrease) in Invested Capital
-257 -253 -73 29 93 430 588 625 458 900 1,253
Enterprise Value (EV)
80,871 96,441 112,935 106,102 86,387 92,191 119,844 143,535 160,331 193,928 395,101
Market Capitalization
78,321 94,106 110,809 104,100 84,285 90,336 118,454 142,334 159,652 192,999 394,116
Book Value per Share
$22.39 $22.89 $25.02 $26.48 $26.80 $30.14 $35.48 $37.78 $41.60 $44.48 $48.61
Tangible Book Value per Share
$1.26 $2.60 $5.08 $6.93 $9.35 $12.96 $18.57 $21.19 $25.32 $28.54 $32.96
Total Capital
8,936 9,724 9,998 10,191 9,467 9,888 10,577 10,870 11,352 11,718 12,237
Total Debt
5,893 6,629 6,630 6,631 5,882 5,883 5,884 5,885 5,886 5,887 5,887
Total Long-Term Debt
5,143 5,879 5,880 5,881 5,882 5,883 5,884 5,885 5,886 5,887 5,887
Net Debt
2,550 2,335 2,126 2,002 2,102 1,855 1,390 1,202 679 929 985
Capital Expenditures (CapEx)
77 72 61 60 92 82 100 96 106 85 89
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,585 1,525 1,616 1,550 1,854 2,006 2,118 2,168 2,074 2,641 3,174
Debt-free Net Working Capital (DFNWC)
4,928 5,819 6,120 6,180 5,634 6,035 6,613 6,851 7,281 7,599 8,077
Net Working Capital (NWC)
4,178 5,070 5,370 5,430 5,634 6,035 6,613 6,851 7,281 7,599 8,077
Net Nonoperating Expense (NNE)
35 29 29 36 26 31 21 24 27 -7.84 4.01
Net Nonoperating Obligations (NNO)
2,550 2,335 2,126 2,002 2,102 1,855 1,390 1,202 679 929 985
Total Depreciation and Amortization (D&A)
99 99 101 96 104 98 96 97 99 99 99
Debt-free, Cash-free Net Working Capital to Revenue
16.38% 15.89% 16.47% 15.12% 17.09% 17.37% 17.43% 17.31% 16.27% 20.17% 23.38%
Debt-free Net Working Capital to Revenue
50.95% 60.63% 62.37% 60.25% 51.94% 52.25% 54.40% 54.70% 57.13% 58.03% 59.48%
Net Working Capital to Revenue
43.20% 52.82% 54.73% 52.94% 51.94% 52.25% 54.40% 54.70% 57.13% 58.03% 59.48%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$4.30 $4.46 $6.22 $7.05 $6.18 $8.21 $9.09 $8.51 $8.73 $9.17 $1.04
Adjusted Weighted Average Basic Shares Outstanding
135.54M 134.95M 135.35M 134.13M 133.33M 132.61M 133.03M 131.76M 131.28M 130.91M 1.31B
Adjusted Diluted Earnings per Share
$4.28 $4.43 $6.16 $7.01 $6.16 $8.16 $9.04 $8.47 $8.68 $9.12 $1.04
Adjusted Weighted Average Diluted Shares Outstanding
136.25M 135.86M 136.19M 134.86M 133.93M 133.30M 133.75M 132.38M 132.01M 131.75M 1.32B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.04
Adjusted Weighted Average Basic & Diluted Shares Outstanding
135.23M 134.64M 134.43M 133.76M 132.89M 132.24M 131.96M 131.39M 131.08M 130.63M 1.31B
Normalized Net Operating Profit after Tax (NOPAT)
803 691 865 982 1,053 1,119 1,224 1,145 1,173 1,193 1,367
Normalized NOPAT Margin
32.27% 29.30% 33.67% 34.56% 34.23% 36.54% 38.54% 35.67% 35.58% 34.94% 37.38%
Pre Tax Income Margin
27.80% 29.75% 36.79% 37.96% 31.61% 41.28% 41.86% 40.80% 40.35% 41.49% 42.36%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
10.32 9.78 12.41 14.13 13.97 18.59 19.17 19.42 20.09 21.12 22.15
NOPAT to Interest Expense
8.33 7.89 10.44 11.95 11.34 15.57 16.73 16.11 16.84 16.94 18.66
EBIT Less CapEx to Interest Expense
9.28 8.88 11.68 13.39 12.74 17.45 17.80 18.07 18.58 19.91 20.93
NOPAT Less CapEx to Interest Expense
7.29 6.99 9.71 11.22 10.11 14.43 15.36 14.76 15.32 15.73 17.44
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
27.30% 28.93% 27.99% 26.62% 25.54% 22.95% 22.27% 22.67% 21.58% 21.55% 21.90%
Augmented Payout Ratio
92.34% 92.31% 90.84% 88.91% 89.75% 82.34% 75.20% 72.89% 66.01% 67.46% 69.30%

Financials Breakdown Chart

Key Financial Trends

KLA’s financial statements show a strong multi-year earnings recovery and accelerating revenue growth. Revenue increased from $2.36 billion in Q4 2023 to $3.66 billion in Q4 2026, while net income rose from $685 million to $1.36 billion. The latest quarter also marked a 15% year-over-year revenue increase and a 13% increase in net income compared with Q4 2025.

Profitability remains a major strength. Q4 2026 gross profit was $2.24 billion, producing a gross margin of approximately 61.4%. Operating income was $1.55 billion, equal to an operating margin of about 42.5%. Although gross margin was slightly below the approximately 62.0% recorded in Q4 2025, operating income continued to grow because of the company’s higher revenue base.

  • Sustained revenue growth: Quarterly revenue advanced from $2.36 billion in Q4 2023 to $3.66 billion in Q4 2026, with revenue increasing sequentially in each reported quarter of fiscal 2026.
  • Strong earnings momentum: Net income climbed from $685 million in Q4 2023 to $1.36 billion in Q4 2026. Fiscal 2026 quarterly net income rose from $1.12 billion in Q1 to $1.36 billion in Q4.
  • High operating profitability: KLA generated approximately $1.55 billion of operating income in the latest quarter, maintaining an operating margin above 40% despite increased research and development spending.
  • Consistent cash generation: Operating cash flow remained positive in every reported quarter, including $906 million in Q4 2026 and $1.37 billion in Q2 2026. This provides substantial funding for dividends, buybacks and investment.
  • Growing liquidity: Cash and short-term investments totaled approximately $4.96 billion at March 31, 2026, compared with roughly $3.35 billion at March 31, 2024. This gives KLA meaningful financial flexibility.
  • Shareholder returns remain substantial: KLA repurchased $571 million of stock and paid $305 million in dividends during Q4 2026. Repurchases have generally exceeded $500 million per quarter during fiscal 2026.
  • Improving balance-sheet equity: Total equity increased to $5.83 billion at March 31, 2026, from $3.00 billion at September 30, 2023, reflecting accumulated earnings and the company’s strong profitability.
  • Investment activity is substantial but largely liquidity-related: KLA regularly purchases and sells hundreds of millions of dollars of investments. These transactions produced negative investing cash flow of $173 million in Q4 2026, but they appear primarily related to managing the company’s investment portfolio rather than aggressive capital expansion.
  • Research and development spending is rising: R&D expense increased from $311 million in Q1 2024 to $399 million in Q4 2026. This reduces near-term margins but may support KLA’s technology position and future growth.
  • Reported EPS data should be interpreted cautiously: Q4 2026 net income of $1.36 billion is shown alongside diluted EPS of $1.04 and 1.32 billion diluted shares, while nearby quarters report approximately 131 million shares and EPS above $8. The Q4 share count and EPS appear inconsistent with the rest of the statements and may reflect a data-standardization issue.
  • Operating cash flow weakened in the latest quarter: Q4 2026 operating cash flow declined to $906 million from $1.16 billion in Q4 2025, despite higher net income. A $644 million use of cash from operating assets and liabilities was the primary reason.
  • Working-capital requirements are increasing: Accounts receivable rose to $2.30 billion and inventory reached $3.44 billion at March 31, 2026. Continued growth in these balances could pressure cash conversion if sales or collections slow.
  • Leverage remains meaningful: Long-term debt was approximately $5.89 billion at March 31, 2026, compared with $5.88 billion two years earlier. While KLA has significant liquidity, debt remains close to the company’s total cash and short-term investments.
  • Cash balances declined during fiscal 2026: Cash and equivalents fell from $2.45 billion at December 31, 2025, to $1.79 billion at March 31, 2026, as buybacks, dividends and investment purchases exceeded operating cash generation.

Overall, KLA’s statements point to a financially strong company with rising revenue, expanding earnings and substantial shareholder distributions. The main issues for investors to monitor are weaker recent cash conversion, elevated working-capital balances, ongoing debt obligations and the apparent Q4 2026 EPS data inconsistency.

08/23/26 12:04 AM ETAI Generated. May Contain Errors.

KLA Financials - Frequently Asked Questions

According to the most recent income statement we have on file, KLA's financial year ends in June. Their financial year 2026 ended on June 30, 2026.

KLA's net income appears to be on an upward trend, with a most recent value of $4.83 billion in 2026, rising from $704.42 million in 2016. The previous period was $4.06 billion in 2025. Check out KLA's forecast to explore projected trends and price targets.

KLA's total operating income in 2026 was $5.66 billion, based on the following breakdown:
  • Total Gross Profit: $8.32 billion
  • Total Operating Expenses: $2.66 billion

Over the last 10 years, KLA's total revenue changed from $2.98 billion in 2016 to $13.58 billion in 2026, a change of 355.0%.

KLA's total liabilities were at $11.60 billion at the end of 2026, a 2.0% increase from 2025, and a 171.5% increase since 2016.

In the past 10 years, KLA's cash and equivalents has ranged from $1.02 billion in 2019 to $2.08 billion in 2025, and is currently $1.65 billion as of their latest financial filing in 2026.

Over the last 10 years, KLA's book value per share changed from 4.43 in 2016 to 48.61 in 2026, a change of 998.4%.



Financial statements for NASDAQ:KLAC last updated on 8/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners